Also known as: Shandong Huizhi Pharmaceutical Technology Co., Ltd.
Highest phase reached
Phase 1
First clinical trial
Last known activity
Nov 20, 2018
No events for the selected filters.
Phase 1 (1 own, 0 via acquisition)